143 related articles for article (PubMed ID: 36915723)
1. ISG15 is a potential therapeutic target for osteosarcoma: a comprehensive analysis based on bioinformatics and in vitro experiments.
Liao Y; Zhang X; Tang J; Hu F; Li D; Song H; Chen J; Guo J; Li R; Lin Y; Xie L
Am J Transl Res; 2023; 15(2):817-833. PubMed ID: 36915723
[TBL] [Abstract][Full Text] [Related]
2. CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway.
Ji H; Kong L; Wang Y; Hou Z; Kong W; Qi J; Jin Y
J Bone Oncol; 2023 Aug; 41():100487. PubMed ID: 37287706
[TBL] [Abstract][Full Text] [Related]
3. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
4. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis.
Zhang W; He R; Cao W; Li D; Zheng Q; Zhang Y
Am J Cancer Res; 2023; 13(11):5094-5121. PubMed ID: 38058813
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
7. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
9. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
10. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
11. A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors.
Li Y; Fu W; Geng Z; Song Y; Yang X; He T; Wu J; Wang B
PeerJ; 2022; 10():e14432. PubMed ID: 36518297
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel key genes associated with the metastasis of prostate cancer based on bioinformatics prediction and validation.
Song F; Zhang Y; Pan Z; Hu X; Yi Y; Zheng X; Wei H; Huang P
Cancer Cell Int; 2021 Oct; 21(1):559. PubMed ID: 34696780
[TBL] [Abstract][Full Text] [Related]
13. PAFAH1B3 Expression Is Correlated With Gastric Cancer Cell Proliferation and Immune Infiltration.
Xie T; Guo X; Wu D; Li S; Lu Y; Wang X; Chen L
Front Oncol; 2021; 11():591545. PubMed ID: 33732641
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of the Oncogenic and Immunological Role of
Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K
Front Oncol; 2022; 12():811567. PubMed ID: 35651805
[TBL] [Abstract][Full Text] [Related]
15. What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance.
Qi J; Liu S; Zhang Z
Cancer Cell Int; 2024 Jan; 24(1):31. PubMed ID: 38218960
[TBL] [Abstract][Full Text] [Related]
16. Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.
Lian H; Xie P; Yin N; Zhang J; Zhang X; Li J; Zhang C
Life Sci; 2019 Sep; 233():116757. PubMed ID: 31419446
[TBL] [Abstract][Full Text] [Related]
17. High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification.
Jiang X; Tang F; Zhang J; He M; Xie T; Tang H; Liu J; Luo K; Lu S; Liu Y; Lu J; He M; Wei Q
Front Oncol; 2023; 13():991483. PubMed ID: 36845726
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
19. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
20. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
